Status:
COMPLETED
Wearable Biosensor to Track and Quantify Limb Dysfunction in Multiple Sclerosis Patients
Lead Sponsor:
Nantes University Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-64 years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) is a leading cause of neurological injury in young adults. Capturing the extent of multiple domains of MS-related disability is critical for effective clinical care and the dev...
Detailed Description
Multiple sclerosis (MS) is a leading cause of neurological injury in young adults. Capturing the extent of multiple domains of MS-related disability is critical for effective clinical care and the dev...
Eligibility Criteria
Inclusion
- Aged between 18 to 64 years inclusive (Patients over 64 years will not be enrolled to avoid possible effect of aging on the voluntary movement assessed);
- Confirmed diagnosis of MS according to the revised McDonald criteria (including primary progressive, secondary progressive and relapsing-remitting MS) with brain lesions consistent with MS if data available;
- No history of relapse in the previous 5 weeks.
- Must be able or think they are able to attempt both finger and foot tapping tests, F2NT, 9HPT and be ambulatory with or without assistance.
Exclusion
- Pregnant women
- Minors
- Adults under guardianship
- Adults over 64 years
Key Trial Info
Start Date :
January 23 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 28 2020
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT03369171
Start Date
January 23 2018
End Date
February 28 2020
Last Update
May 19 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France, 44093